23 related articles for article (PubMed ID: 8628538)
1. Survival from childhood acute lymphoblastic leukaemia in West Germany: does socio-demographic background matter?
Erdmann F; Kaatsch P; Zeeb H; Roman E; Lightfoot T; Schüz J
Eur J Cancer; 2014 May; 50(7):1345-53. PubMed ID: 24582913
[TBL] [Abstract][Full Text] [Related]
2. Endings and the end of treatment bell in paediatric cancer treatment for acute lymphoblastic leukaemia: An interpretative phenomenological analysis of children's perspectives.
von Werthern M; Sweet R; Tsipa A; Caliskan I; Clements H; Alcock K; Soon K
J Cancer Policy; 2023 Dec; 38():100442. PubMed ID: 37648153
[TBL] [Abstract][Full Text] [Related]
3. Late effects in survivors of infant acute lymphoblastic leukaemia-a study of the Australian and New Zealand Children's Haematology/Oncology Group.
Mironova D; Saraswati CM; Downie P; Lai CY; Cook E; Carruthers V; Moukhaiber P; Molloy F; Serov J; McKinnon E; Alvaro F; Osborn M; Revesz T; Prestidge T; Cross S; Bateman CM; Moore AS; Khaw SL; Mateos MK; Kotecha RS
Blood Cancer J; 2023 Sep; 13(1):150. PubMed ID: 37752126
[No Abstract] [Full Text] [Related]
4. Management of Ontario children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocols.
Desai SJ; Barr RD; Andrew M; deVeber LL; Pai MK
CMAJ; 1989 Oct; 141(7):693-7. PubMed ID: 2790605
[TBL] [Abstract][Full Text] [Related]
5. Intravenous 6-mercaptopurine decreases salvage after relapse in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group study CCG 1922.
Tolar J; Bostrom BC; La MK; Sather HN
Pediatr Blood Cancer; 2005 Jul; 45(1):5-9. PubMed ID: 15481062
[TBL] [Abstract][Full Text] [Related]
6. Childhood acute lymphoblastic leukaemia: outcomes of 54 consecutive patients treated in Auckland 1985-1991.
Mauger DC; Skeen JE
N Z Med J; 1998 Nov; 111(1078):454-6. PubMed ID: 9891565
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
8. Acute lymphoblastic leukaemia: the Wellington experience 1980-92.
Bailey S; Lewis M
N Z Med J; 1996 Jan; 109(1014):9-11. PubMed ID: 8628538
[TBL] [Abstract][Full Text] [Related]
9. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected].
Magrath I; Shanta V; Advani S; Adde M; Arya LS; Banavali S; Bhargava M; Bhatia K; Gutiérrez M; Liewehr D; Pai S; Sagar TG; Venzon D; Raina V
Eur J Cancer; 2005 Jul; 41(11):1570-83. PubMed ID: 16026693
[TBL] [Abstract][Full Text] [Related]
10. Personalization of dexamethasone therapy in childhood acute lymphoblastic leukaemia.
Jackson RK; Irving JA; Veal GJ
Br J Haematol; 2016 Apr; 173(1):13-24. PubMed ID: 26729065
[TBL] [Abstract][Full Text] [Related]
11. Neoplasia in childhood--25 years of progress.
Mott MG
Ann Oncol; 1995; 6 Suppl 1():3-8; discussion 8-9. PubMed ID: 8695541
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
